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Background: The outcome of an Entamoeba histolytica infection is variable and can result in either asymptomatic
carriage, immediate or latent disease (diarrhea/dysentery/amebic liver abscess). An E. histolytica multilocus
genotyping system based on tRNA gene-linked arrays has shown that genetic differences exist among parasites
isolated from patients with different symptoms however, the tRNA gene-linked arrays cannot be located in the
current assembly of the E. histolytica Reference genome (strain HM-1:IMSS) and are highly variable.
Results: To probe the population structure of E. histolytica and identify genetic markers associated with clinical
outcome we identified in E. histolytica positive samples selected single nucleotide polymorphisms (SNPs) by
multiplexed massive parallel sequencing. Profile SNPs were selected which, compared to the reference strain HM-1:
IMSS sequence, changed an encoded amino acid at the SNP position, and were present in independent
E. histolytica isolates from different geographical origins. The samples used in this study contained DNA isolated
from either xenic strains of E. histolytica trophozoites established in culture or E. histolytica positive clinical
specimens (stool and amebic liver abscess aspirates). A record of the SNPs present at 16 loci out of the original
21 candidate targets was obtained for 63 of the initial 84 samples (63% of asymptomatically colonized stool
samples, 80% of diarrheal stool, 73% of xenic cultures and 84% of amebic liver aspirates). The sequences in all the
63 samples both passed sequence quality control metrics and also had the required greater than 8X sequence
coverage for all 16 SNPs in order to confidently identify variants.
Conclusions: Our work is in agreement with previous findings of extensive diversity among E. histolytica isolates
from the same geographic origin. In phylogenetic trees, only four of the 63 samples were able to group in two sets
of two with greater than 50% confidence. Two SNPs in the cylicin-2 gene (EHI_080100/XM_001914351) were
associated with disease (asymptomatic/diarrhea p = 0.0162 or dysentery/amebic liver abscess p = 0.0003). This study
demonstrated that there are genetic differences between virulent and avirulent E. histolytica strains and that this
approach has the potential to define genetic changes that influence infection outcomes.Background
The eukaryotic parasite Entamoeba histolytica, the caus-
ative agent of amebiasis, is a major cause of morbidity
and mortality worldwide, as well as a category B priority
biodefense pathogen [1]. In Dhaka, Bangladesh, surveys
done in a cohort of children living in an urban slum
showed evidence of E. histolytica infection (determined* Correspondence: cg2p@virginia.edu
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reproduction in any medium, provided the orby detection of parasite antigen in either diarrhea or
monthly surveillance stool) in 80% of the children tested
[2]. Host genetics can influence susceptibility to infec-
tious disease and a single amino acid substitution in the
host cytokine receptor homology domain 1 of LEPR and
a difference in the leukocyte antigen class II allele ex-
pressed are associated with increased susceptibility to in-
testinal infection by the E. histolytica [3,4]. Symptomatic
disease occurs in only a minority of E. histolytica infec-
tions (20%) in an unpredictable manner and an initially
asymptomatic infection can over time convert to invasivel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Gilchrist et al. BMC Microbiology 2012, 12:151 Page 2 of 14
http://www.biomedcentral.com/1471-2180/12/151disease (~12.5%), amebic liver abscess can occur years
after travel to an endemic area [5,6]. It is hypothesized
that both host and parasite factors contribute to the out-
come of an E. histolytica [7]. However, although progress
has been made in both the identification and character-
ization of parasite virulence factors and in understanding
the regulation of their gene expression, direct manipula-
tion of the E. histolytica genome remains elusive, and the
traits affecting parasite virulence have not been genetic-
ally mapped [8-17].
Despite this variations that occur within repeat-
containing genes in the amoeba genome chitinase and
serine-rich E. histolytica protein [SREHP] have been
used to examine the link between E. histolytica genetics
and disease [18-22]. The high rates of polymorphism
however at the loci make it difficult to use them for this
purpose and an association between some of these mar-
kers and virulence has not been proven in large scale
studies [18,21]. However, based on the composition of
highly repetitive tRNA arrays, E. histolytica has been
shown to have distinct genotypes with different poten-
tials to cause disease [23-27].
E. histolytica tRNA genes are unusually organized in
25 arrays containing up to 5 tRNA genes in each array,
with intergenic regions between tRNA genes containing
short tandem repeats (STRs) [27]. A 6-locus (D-A, S-Q,
R-R, A-L, STGA-D, and N-K) tRNA gene-linked genotyp-
ing system has shown that the number of STRs at these
loci differ in parasite populations isolated from three
clinical groups (asymptomatic, diarrhea/dysentery and
liver abscess) [24,26]. The variations occurring in tRNA
genotypes, even between the ameba strains isolated from
the intestine and in the liver abscess of the same patient,
suggest that not all strains of E. histolytica have the same
capacity to reach the liver of the infected host [28].
However, the diversity of tRNA linked STR genotypes
occurring even in a restricted geographic region, and the
frequent occurrence of novel genotypes, limit their use-
fulness to predict infection outcome or to probe the
population structure of E. histolytica [25,29,30]. The ex-
tensive genetic polymorphism in the repeat sequences of
SREHP, chitinase and tRNA arrays for instance could re-
flect slippage occurring during E. histolytica DNA repli-
cation as Tibayrenc et al. hypothesize that the parasites
exist as clonal populations that are stable over large geo-
graphical areas and long periods of time [31,32].
Compared with other DNA markers, single nucleotide
polymorphisms (SNPs) are genetically stable, amenable
to future automated methods of detection, and in con-
trast to the highly repetitive tRNA arrays, their location
can be mapped in the E. histolytica genome [33-35].
After the first sequencing and assembly of Entamoeba
histolytica HM-1:IMSS genome was published by Loftus
et al. Bhattacharya et al. amplified and sequenced 9 kbof coding and non-coding DNA to evaluate the variabil-
ity of E. histolytica SNPs in 14 strains and identified a
link between some genotypes and clinical outcome [36].
The advent of the next generation of high throughput
genomic sequencing (NGS) technologies has provided
more comprehensive opportunities to investigate vari-
ation in the genome of E. histolytica and clinical out-
come by allowing the fast and efficient way to sequence
laboratory-cultured ameba of clinical relevance [35,37].
These cultured strains were isolated from different geo-
graphical areas endemic for amebiasis and contained
large numbers of “strain-specific” SNPs in addition to
SNPs present in more than one strain [35]. The sequence
variations associated with virulence strains previously
identified in the sequenced 9 kb DNA (a synonomous
SNP in XM_001913658.1the heavy subunit of the Gal/
GalNAc lectin gene (894A/G), and SNPs in the non-coding
DNA either between XM_652295.1 and XM_652296.2 se-
quences (236T/G, 240A/G and 561T/G) or 5’ of the Amoeba-
pore C transcript XM_650937.2 (407A/C and 422A) seemed
to be present only the two to four Bangladesh isolates
sequenced by Bhattacharya et al. and were not present in
the available international sequenced whole genomes
[36].
The goal of this work was to develop a set of less vari-
able markers to profile a large number of strains from
different regions of the globe, therefore we selected add-
itional non-synonomous SNPs which Bhattacharya et al.
had shown to be less variable, to probe the population
structure of E. histolytica in depth [36]. The new SNPs
were present with a frequency of 0.3-0.6 in the pool of
geographically disparate E. histolytica parasites whose
genomes had been sequenced. We restricted our SNP
candidates for initial analysis to genes with the potential
to be involved in the virulence of this parasite [8-17]. As
our current hypothesis is that the development of dis-
ease is multifactorial, or polygenic, and involves a com-
bination of parasite factors in the current work we
selected several loci to test for their association with dis-
ease outcome in E. histolytica. These loci contained
SNPs that resulted in non-synonomous changes to the
encoded amino acids, were present in more than three
of the sequenced E. histolytica genomes, and enriched
either in strains originating from symptomatic or asymp-
tomatic infections. We have shown that two of these
SNPs were significantly associated with disease severity
in Bangladesh isolates.
Results
Initial identification and validation of single nucleotide
polymorphisms identified using Next Generation
Sequencing
The genome sequencing projects of multiple E. histoly-
tica strains performed at the J. Craig Venter Institute
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versity of Liverpool) provided the sequence data used
for the identification of SNPs (Table 1) [35]. A total of
10,855 SNPs within coding DNA were identified in the
sequenced genomes (Additional file 1: Table S1). Each
strain had approximately 1,500 homozygous and 1,000
heterozygous SNPs. Half of all the SNPs identified
were unique and present in only one strain (“private”
SNPs). Like Ghosh et al. we identified mainly di-
morphic SNPs, while potential tri- and tetrazygote var-
iants were very infrequent [22]. This, however, may
reflect a bias in SNP detection programs because
Mukherjee et al. observed considerable heterogeneity
in the ploidy of E. histolytica [38].
To validate the use of SNPs from next generation se-
quencing data, a set of 12 SNPs predicted by NGS were
verified by conventional Sanger sequencing of PCR
amplicons from three selected strains, MS96-3382 (MS
indicates monthly stool; this strain was established from
an asymptomatic infection), DS4-868 (DS indicates diar-
rheal/dysenteric stool; this strain was isolated from a
symptomatic infection) (sequenced as described in Add-
itional file 1: Table S1) and the reference sequence HM-
1:IMSS (Table 2). Primers were designed to amplify the
region containing each SNP. The primers used are de-
tailed in Additional file 1: Table S2 and the amplicons
are shown in Additional file 1: Table S3 (primer sequencesTable 1 Genomes sequenced by the Genomic Sequencing
Center for Infectious Diseases (GSCID) and the Institute
of Integrative Biology, E. histolytica Genome sequencing
projects
Strain id Genbank identifier
if available
Source/reference
GSCID E. histolytica Genome Sequencing Project
MS96-3382 885314 R. Haque, unpublished
data ICDDR,B
DS4-868 885310 Ali et al. 2007 [24]
KU 27 885311 Escueta-de Cadiz et al. 2010 [29]
KU 50 885313 Escueta-de Cadiz et al. 2010 [29]
KU 48 885312 Escueta-de Cadiz et al. 2010 [29]
University of Liverpool E. histolytica Genome Sequencing Project
HK-9 Ungar et al., 1985 [39]
PVBM08B University of Liverpool genome
resequencing project [35]
PVBM08F University of Liverpool genome
resequencing project [35]
2592100 R. Haque, unpublished data ICDDR,B
Rahman Diamond, and Clark. 1993 [40]
MS84-1373 R. Haque, unpublished data
ICDDR,B [35]
MS27-5030 R. Haque, unpublished data
ICDDR,B [35]underlined). PCR was performed with these primers on
MS96-3382, DS4-868, and HM-1:IMSS genomic DNA
as described in materials and methods. The amplified
products were separated on a 2% agarose gel and DNA
fragments of the correct size were gel purified and se-
quenced by Sanger sequencing. In all cases the results of
the Sanger sequencing of the MS96-3382 and DS4-868
amplicons matched the sequence produced by the NGS
(Table 2, Additional file 1: Table S1). The Sanger data
from HM-1:IMSS also matched the reference genome
however a SNP in the alcohol dehydrogenase gene (gene
ID EHI_166490/XM_647170.2) was heterozygous in this
HM-1: IMSS reference strain, which was not previously
known (Table 2). We therefore concluded that E. histoly-
tica single nucleotide polymorphisms studied here were
accurately identified.Candidate single nucleotide polymorphisms
The resampling results described above indicated that
SNPs were maintained within an E. histolytica strain
under continuous culture. However, this does not ex-
clude the possibility that a particular genotype may
change in frequency within an endemic population. To
test for association between SNPs and disease outcome,
E. histolytica samples were collected from an area en-
demic for amebiasis (ICDDR and Rajshahi Medical Col-
lege, Rajshahi, Bangladesh- Additional file 1: Table S4).
Both field samples and xenic cultures established from
asymptomatic and symptomatic infections were used as
a source of DNA (19 amebic liver aspirates; 26 xenic
cultures (14 established from asymptomatic infections
and 12 from diarrheal); 20 E. histolytica positive sam-
ples from diarrheal stool; and 19 E. histolytica positive
samples collected during monthly stool sample surveil-
lance). We anticipated that the virulence of this parasite
in humans may not be the direct target of selection, be-
cause invasive disease does not seem to confer an ad-
vantage to pathogen dissemination [41]. To focus on
potentially genetically stable SNPs, which were never-
theless variably present in the different stains, we
selected non-synonomous SNPs in the available data
that were present in at least four, but not more than
nine genomes. This allowed us to select for poly-
morphic SNPs that frequently occur in ameba and may
represent genetically stable or ancestral variants that re-
main at a frequency of 0.3 to 0.6 a frequency that gave
us sufficient statistical power to detect 2x differences
within the amebic population surveyed in this study.
For a SNP to be considered a candidate for association
with symptomatic disease it had to occur at a greater fre-
quency in the isolates from symptomatic amebic infec-
tions. Twenty-one potentially informative loci were chosen
for further analysis in a larger number of E. histolytica
Table 2 Verification, by Sanger sequencing, of 12 polymorphic loci identified by Next Generation Sequencing (NGS) of
E. histolytica genomes
Strain HM-1:1MSS DS4-868 MS96-3382
Genbank accession number Gene id Reference sequence NGS Sanger NGS Sanger NGS Sanger
XM_644365 EHI_103540 63883C C C C C C/A C/A
XM_645788 EHI_069570 120673G G G A A A A
XM_647032 EHI_134740 54882G G G G G A A
XM_651435 EHI_041950 9878A A A A A C C
XM_647310 EHI_065250 10296C 10297T CT CT TC TC TC TC
XM_647310 EHI_046600 6048A A A C C C C
XM_647170 EHI_166490 28371G G G/A G G G/A G/A
XM_652055 EHI_049680 91356A A A A A C C
XM_648588 EHI_188130 32841C C C T T T T
XM_001914355 EHI_083760 807T T-x-G T-x-G T-x-G T-x-G T-x-A T-x-A
784G
XM_647392 EHI_126120 105607A A A A A G G
XM_001913688 EHI_168860 11109G G G A A A A
Verification of SNPs identified during Next Generation Sequencing of E. histolytica genomes.
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(Additional file 1: Table S5 and S6).
SNP genotyping of E. histolytica clinical isolates
The 21 marker loci selected from whole genome se-
quencing data were used to genotype clinical isolates
of E. histolytica. DNA isolated from three sources,
stool samples, short term xenic cultures of parasites
from stool and amebic liver abscess aspirates, was used
as a template to amplify the 21 loci. PCR products
were sequenced using Illumina sequencing technology
and the resulting demuliplexed sequence reads aligned
to reference sequences representing the genes to which
each amplicon corresponds in order to determine the
nucleotide(s) present in the sampled genomes (see
Additional file 1: Table S7).
Five of the 21 targets were not consistently co-
amplified in our PCR reactions. This could have been
due to differences in primer efficiency or off-target amp-
lification in the xenic culture and stool specimens that
contain an undefined mixture of intestinal microflora or
it may also be because the gene is missing from some
isolates or highly divergent. These five loci were not
included in later analyses that only used the 16
remaining loci. We selected only those samples where
all target sequences were efficiently amplified and we
observed good coverage of all the expected amplicon
sequences. If one or more of the targets was missing,
then the sample was eliminated (Additional file 1: Table
S7). The final data set consisted of 63 or the original 84
samples (63% of asymptomatically colonized stool sam-
ples, 80% of diarrheal stool, 73% of xenic cultures and84% of amebic liver aspirates) which passed quality con-
trol and had the greater than 8 fold sequence coverage
needed to confidently call SNPs.
The libraries generated from stool samples and from
polyxenic culture contained a greater number of reads
that did not map to the E. histolytica amplicons than
those obtained from amebic liver abscess aspirates. This
was likely due in part to off-target amplification (Figure 1)
of gut flora, or a reduction in specificity because most of
these samples did not undergo nested PCR amplification
prior to library preparation. Samples isolated from
amebic liver aspirates do not have associated bacterial
flora, unlike pyloric abscesses, therefore a higher propor-
tion of the template DNA is E. histolytica.
In the samples that passed quality control, the read
depth for individual SNPs was >8x coverage; this was
considered adequate for SNP verification. SNPs were
scored as described in materials and methods. The
results of the illumina sequencing and the presence of
predicted and novel SNPs within the amplicon se-
quences was tabulated as homozygous Reference (the
same as the reference HM-1:IMSS sequence at this pos-
ition) heterozygous (contained both the HM-1:IMSS nu-
cleotide and the variant nucleotide at this position) or
homozygous Non-Reference (has only the variant base
at this location) (Additional file 1: Table S8). In Figure 2
the diversity of the SNPs at each locus in both the ori-
ginal sequence data (genomes shown in Table 1), and in
the Bangladesh samples analyzed in this study, (extra
details shown in Additional file 1: Table S9).
Our work supports previous finding of extensive diver-
sity among E. histolytica isolates from the same geographic
Figure 1 Amplicon sequencing efficiency for individual samples. A) Number of reads obtained from the Illumina libraries prepared from
different sample source x-axis libraries prepared from different sample source; y-axis number of reads (log2 scale) B) Average coverage of the
reads when mapped to the concatenated amplicon reference; x-axis libraries prepared from different sample source y-axis average coverage of
mapped reads (log2 scale) Line indicates median number of reads.
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could be grouped into two sets of two with greater than
50% confidence suggesting that the genotypes of individual
parasites do not contain consistent phylogenetic signals
(Figure 3). Such a result suggests that the markers do not
share the same genealogy, likely due to extensive recom-
bination or re-assortment breaking down linkage between
markers. The diversity of E. histolytica genome raises a
concern in regard to later analysis as it raises the possibility
that a rapid rate of evolution may drive any observed dif-
ferences between E. histolytica genotypes in samples iso-
lated in regions separated even by relatively small
geographical distances.
The effect of adaptation of to in vitro culture on SNP
allele frequencies
To examine the potential effect of adaption to in vitro
culture on the frequency of SNP alleles, and therefore
how well transiently or long established cultured tropho-
zoites represent the parasite population, SNP allele fre-
quencies were compared between parasites genotyped
directly from stool samples and those from cultured tro-
phozoites (Additional file 1: Table S10).
In cultures originating from asymptomatic isolates five
linked Non-Reference SNPs at the LCAT EHI_065250/
XM_647310.1 locus were detected in 80% of the strains,these same SNPs occurred in only 16% of the E. histolytica
positive stool samples from asymptomatic hosts (Figure 4).
This suggests that during establishment of E. histolytica
cultures a strong selection pressure was exerted on se-
quence in linkage with the LCAT EHI_065250 gene. This
could either cause growth failure of the strains with the
Reference allele or the outgrowth of a minority genotype
in mixed infections (previous studies using the short tan-
dem repeats have indicated that mixed infections are rare
however this possibility cannot be discounted [24]).
To confirm that this change in the distribution of the
Non-Reference SNPs was due to culture conditions, and
not due to the Bangladesh origin of these samples, the
comparison was repeated using only the strains isolated
and transiently established in culture at ICDDR, B and
genotyped using MLST during this study. A similar
trend was observed.
EHI_065250 (LCAT) belongs to a gene family that
consists of ten genes; they range in identity from 82% to
51% (Additional file 2: Figure 1A and B); two are highly
similar to EHI_065250 (82 and 81% identity). The pri-
mers used in SNP amplification were specific for
EHI_065250 and did not amplify the other members of
this gene family. The other LCAT gene sequences are
sufficiently different that off-target amplification would
be detected in the sequence alignments of the Illumina
Figure 2 Similarity of E. histolytica diversity in Bangladeshi and whole genome sequenced strains. Shown on the y axis (H) is the
calculated heterozygosity and represents sum of the squared allele frequencies was subtracted from 1 on the x axis the loci containing the SNPs
genotyped by MSLT(■ value in Bangladesh samples genotyped during this study, (□ value in the sequenced genomes described in Table 1).
Figure 3 Lack of consistent patterns of descent among SNP markers from Bangladeshi E. histolytica isolates suggests they segregate
independently. Consensus phylogeny inferred from 100 bootstrap replicates of polymorphic SNP markers, constructed using the MEGA 5
program and the Maximum Likelihood method based on the Tamura-Nei model and using the sequences shown in Additional file 1: Table 8 [42].
Branches produced in fewer than 50% of the bootstrap phylogenies were collapsed. Sequences from stool have the suffix s; culture c; monthly
survey stools begin with MS or CMS, diarrheal DS or CDS, amebic liver abscess samples RUF.
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 Ref; homozygous   
 Reference allele
het; heterologous    
 Reference/Non-
 Reference allele 
Non-Ref; homozygous 
          Non-Reference   
          allele
Figure 4 Amebic culture effect on the EHI_065250 Entamoeba genotype. Distribution of the EHI_065250 SNP at the 10296 location in field
isolates or cultured strains established from asymptomatic disease (p = 0.0166). The distribution of the individual SNPs, which were either
Reference (Ref), Non-Reference (Non-Ref) or heterologous was shown on the x-axis. The number of samples of with this genotype isolated from
patients with asymptomatic disease was shown on the y-axis.
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confirming that amplification was specific for the target
EHI_065250 locus.
The effect on SNP genotype was only apparent for the
LCAT EHI_065250 SNPs and the p value of the
EHI_065250 SNPs was not sufficiently low to eliminate
the possibility of false discovery (q value = 0.32, Add-
itional file 1: Table S10). Therefore the cultured strains
were included in Table 3 and the statistical association
of SNPs with disease phenotype was determined using
the complete dataset but confirmed using the data set
with only clinical samples (Additional file 1: Table S11
Data Set 1 and 2).
Genetic differences between virulent and avirulent E.
histolytica strains
The EHI_080100/XM_001914351.1 cylicin-2 locus con-
tained two closely linked SNPs 1&2. These SNPs were
significantly associated phenotype (Non-Reference SNP
was present in 75% of ALA samples; positive samples
or cultures isolated from the monthly survey stool 52%
and in 16% of samples or cultures isolated from diar-
rheal stool; p = 0.002; q = 0.032; Figure 5). Both the
Reference and the Non-Reference variants at this locus
were present in asymptomatic samples however the
Non-Reference variants were more frequent in liver
abscess samples and less frequent in samples isolated
from patients with diarrhea/dysentery (Figure 5 pair
wise comparison between asymptomatic and diarrhea/
dysentery p = 0.0182 and between amebic liver abscess
and diarrhea/dysentery samples p = 0.0003; q = 0.0144).
Amebic liver abscess is a complication only found in
adults whereas dysentery is more frequent in children.
The liver aspirate samples in this study were collected
from adults, at Rajshahi Medical College Hospital,Bangladesh. This is a geographically distinct location
from the dysenteric and asymptomatic samples that
were collected from children in Dhaka, Bangladesh.
One goal of this study was to identify SNPs to type the
virulence potential of the parasite in amebic liver aspi-
rates; if SNPs occur at different frequencies in Dhaka
and Rajshahi isolates they will appear as potential bio-
markers of parasites with the potential to initiate
amebic liver abscesses. The difference in SNP 1&2 fre-
quency in both asymptomatic and diarrheal samples
was replicated however in the sequenced genomes from
diverse populations in Asia and South America
(described in Table 1 and Additional file 1: Table S6 and
included in Data set 2 Additional file 1: Table S11)
[24,29,35,39].
The previously discussed locus, LCAT EHI_065250,
which contained five different SNPs (3–7), was also asso-
ciated with symptomatic disease however possible selec-
tion in culture rendered the distribution less significant
within the larger data set (Table 3).
The changes at both the LCAT EHI_065250 and the
cylicin-2 EHI_080100 loci altered a potential phosphor-
ylation site in the encoded protein sequence (NetPhos
[43]), and are located at the C-terminal portion of the
proteins (Figure 6). Expression of EHI_065250 has been
shown to be modulated in the mouse model of amebia-
sis, and to be under the control of the URE3-BP tran-
scription factor [9,44]. EHI_080100 appears to be a
novel member of the E. histolytica “promoter family” po-
tential membrane proteins regulated by the transcription
factor URE3-BP with highly similar promoters, and
amino- and carboxyl-terminal sequences (sites of signal
peptide and transmembrane domains) [44]. EHI_080100
encodes a hydrophilic Glutamic acid/Lysine rich protein
with an N-terminal Signal P and although annotated as
Table 3 Association of SNPs with disease phenotype
Significance of SNP distribution in
Invasive amebic liver abscess,







SNP p value q-value
XM_647889.1& EHI_080100 Pro361Leu 2725C/T 1 0.002** 0.032**
XM_647310.1& EHI_065250 Ser399Asp 10296A/G 3 0.05** 0.3
10297G/A 4
XM_644633.2 EHI_200030 Leu60Ile 16181C/A 8 0.08 0.31
XM_646031.2 EHI_120270 Pro21Ser 7994C/T 9 0.10 0.31
XM_647889.1 EHI_008810 Leu326Ile 73463C/A 10 0.24 0.44
XM_643253.1 EHI_040810 Ala197Glu 1216C/A 11 0.31 0.46
XM_645270.1 EHI_105150 Ile282Met 27395T/G 12 0.42 0.56
XM_001913781.1 EHI_138990 Val1288Leu 30231G/T 13 0.52 0.64
XM_651449.1 EHI_042210 Pro58Leu 39051C/T 14 0.92 1.00
XM_648423.2& EHI_016380 Tyr702His 17795T/C 15 0.97 1.00
#Only loci with diversity H value over 0.25 shown.
** <0.05.
&Representative SNP chosen in linked SNP data sets.
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Its function remains unknown.
Discussion
E. histolytica SNPs were identified in amebic DNA isolated
from a Bangladesh population by amplicon sequencing.
Non-Reference SNPs in the EHI_080100 cylicin-2 gene
were significantly associated with the virulence pheno-
type (amebic liver abscess> asymptomatic> diarrhea or
dysentery).
We initially analyzed the genetic diversity among 12
sequenced E. histolytica genomes that representedFigure 5 SNPs 1&2 in the EHI_080100 locus segregate with disease. D
Non-Reference (■ ALA);(Non-Ref) was shown on the x-axis. The number of
amebic liver abscesses diarrhea/(D/D) asymptomatic disease COL was show
and diarrhea/dysentery p = 0.0182 (*); between amebic liver abscess and di
Chi-squared contingency analysis of all phenotypes p = 0.002; q = 0.032 (**)different geographical origins and disease manifesta-
tions, and selected a set of 21 polymorphic sites in
coding regions where SNPs change the encoded amino
acid. The distribution of these 21 non-synonymous
SNPs in field isolates and cultured strains of E. histoly-
tica were examined in samples collected from an en-
demic area in Bangladesh by multilocus sequence
typing (MLST). Of 16 loci that passed quality control
five were invariantor very infrequent in Bangladesh.
Our results are inconsistent with a model of clonality in
E. histolytica populations. In a clonal population we
would expect to see strong linkage disequilibriumistribution of the SNP1 which was either Reference (□,MS)(Ref),
samples of with this genotype isolated from patients with either
n on the y-axis. Fisher’s pairwise comparison between asymptomatic
arrhea/dysentery samples p = 0.0003; q = 0.0144 (**);
.
Figure 6 The locationof the SNPs1&2 in EHI_080100 and
EHI_065250 genes. Mapping of the informative SNPs within the
coding sequences. A) EHI_065250 and B) EHI_080100 genes.
Nucleotide position of the amplicon 5’ and 3’ bases are shown and
approximate location of the 5’ (green) and 3’ (red) and the positions
and number of the targeted SNPs indicated by vertical lines. The
bases involved are bracketed in the nucleotide sequence at this
region (shown above). The amino acid sequence with changed
residues in red is also shown.
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by recombination and sexual reassortment. In fact, we
saw only two identical genotypes in our sample, suggest-
ing a considerable amount of recombination and/or re-
assortment. Our results support previous observations,
based on short tandem repeat DNA sequences, of high
diversity among genotypes even within limited geograph-
ical areas [18,21,24]. Due to this complexity, the num-
ber of whole genomes sequenced in the pilot studies,
were not sufficient to predict accurately the SNPs asso-
ciated with disease. However, 2 out of the 16 loci
examined, (EHI_065250 and EHI_080100), were signifi-
cantly associated with disease in isolates collected in
Rajshahi and Dhaka, Bangladesh.
One caveat to this study was that the amebic liver ab-
scess samples were collected in Rajshahi but the stools
samples were collected at a different location (Mirpur,
Dhaka); the differences in the grouping of liver abscess
and stool E. histolytica could reflect geographical dif-
ferentiation [24]. Ali et al. have however previously de-
scribed different genotypes in liver abscess and enteric
samples from the same patients [28]. This suggests a
possible genetic selection for parasites with invasive cap-
abilities. Based on our data we suggest a divergent rather
than sequential model of the potential to cause severe
disease [46]. Non-Reference EHI_080100 SNPs were
more frequent in asymptomatic than diarrhea/dysentery
samples. However the Non-Reference SNP potentially
predisposed the asymptomatic infection to initiate anTable 4 Locations of informative SNPs
Gene id Contiguous E. histolytica DNA region ID
EHI_080100 DS571720
EHI_065250 DS571302
Genomic Location of the SNPS in the EHI_080100 and EHI_065250 genes.amebic liver abscess rather than amebic colitis (p =
0.0182) as the Non-Reference EHI_080100 SNPs, were
present with even higher prevalence, in samples from
amebic liver abscess (p = 0.0003, q = 0.0144). Additional
studies are needed to identify additional amebic biomar-
kers associated with invasive disease.
In both EHI_065250 and EHI_080100 the consequence
of the Non-Reference polymorphisms was to change two
amino acids within the C-terminal domains. The reason
behind the association of these SNPs with invasive dis-
ease is not yet clear. The polymorphic genes have not
previously been associated with a virulent phenotype,
and other than the previously discussed change in at a
potential phosphorylation site, there were no other pre-
dicted changes in protein function using the currently
available bioinformatics tools (PolyPhen http://genetics.
bwh.harvard.edu/pph2/, http://sift.jcvi.org/www/SIFT_
seq_submit2.html) [47,48].
EHI_080100 (cyclin-2) is present on a short region of
contiguous DNA in the E. histolytica HM-1:IMSS gen-
ome assembly that could not be assembled into a larger
contiguous DNA segment or sequence scaffold (Table 4).
This suggests that the gene may be present in proximity
to highly repetitive regions that prevent unambiguous
assembly. Lorenzi et al. suggest that repeats and repeat-
clusters are found at syntenic break points between
E. histolytica and E. dispar and could act as recombination
hot spots promoting genome rearrangement [49]. This
“informative” locus could therefore reside in regions of
DNA prone to allelic imbalance. In addition, no E. dispar
homologue has been found for EHI_080100, making this
gene an interesting candidate for further studies.
The currently identified SNPs could act as genetic
“markers” in incomplete linkage disequilibrium with
neighboring DNA that contains causative or regulatory
SNP (r-SNP) mutations that result in a modulation of
gene expression. It is interesting to note that contiguous
with the EHI_065250 gene is one of the genes encoding
the intermediate subunit of the Galactose- and N-acetyl-
D-galactosamine (Gal/GalNAc) inhibitable lectin (igl2)
[50]. The Gal/GalNAc inhibitable lectinis a well-
characterised virulence factor in E. histolytica [51].
It is also possible that amino acids changes resulting
from the SNPs directly influence the biological activity
of the encoded protein and that these changes affect the
ability of the trophozoite to invade its host. What has
never been clear is the advantage to the E. histolytica
parasite to the causation of invasive disease [41]. It isLength (bp) Location of SNP(s) (bp)
5179 2725-2730
38246 10296-10318
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the coevolving genomes of parasite and host and are the
reason for the expression of the virulent E. histolytica
phenotype [3,4]. The effect of the changes described in
this study on the stability and function of the encoded
protein is currently under investigation.Conclusions
E. histolytica does not follow the model of T. gondii
that exists predominantly in a few main lineages [52].
Rather, even in population from a single geographic lo-
cation, majority of the individual parasites show unique
genotypes. The number of tRNA-linked genotypes dis-
covered, are likely to continue increasing in number
and will enable the measurement of strain diversity.
However, the results presented in this work support the
hypothesis that a relationship exists between the geno-
type of an E. histolytica strain and parasite virulence.
Unlike the tRNA-linked sequence types (Ali et al, 2012)
which are merely surrogate markers for the prediction
of infection outcomes, non-synonymous SNPs detected
in the present study shows promise to identify parasite
factors directly linked to infection outcomes [26]. Al-
though preliminary, our findings identified two candi-
date genes that may contribute to the pathogenesis of
these parasites. The level of genetic variation we
observed increases the importance of the SNPs we have
linked to disease. We are currently investigating the im-
pact of the non-synonomous changes on the function
of these proteins.
To fully understand the genetics of this parasite, add-
itional biomarkers will be needed to understand virulence
and different outcomes of the disease at the genome level.
In the absence of stable clonal populations deeper
characterization of the variation in the E. histolytica gen-
ome requires sequences from additional ameba strains.
Using the protocol described in this paper usable se-
quence data was gathered from approximately half of the
field samples. This allowed the testing of the association
of selected candidate SNPs within an endemic population.
Given the large amount of variation that occurs, SNPs
need to be carefully chosen to type the virulence potential
in an E. histolytica MLST schema rather than to reflect
parasite phylogeny. Future studies are needed which focus
on the genome of the infecting parasite in conjunction
with the genome of the infected host.Methods
Ethical approval
The Ethical Review Committee at ICCDR,B approved
this study. Written informed consent was provided by
all study participants and/or their legal guardians.Cultured E. histolytica strains used for genotyping
E. histolytica trophozoites isolated from patients of all age
groups seen at the hospital for diarrheal diseases, or from
children living in an urban slum area in Dhaka were estab-
lished in culture at the International Centre for Diarrhoeal
Diseases Research, Bangladesh (ICDDR,B). Polyxenic cul-
tures were maintained in biphasic Robinson's medium at
37°C (listed in Additional file 1: Table S4) [53].
E. histolytica DNA derived from stool samples
Recently collected stools from patients of all age groups
seen at the hospital for diarrheal diseases, or from children
living in an urban slum area in Dhaka were examined
macroscopically for the presence of blood and mucus;
a smear of feces in 0.9% saline was examined micro-
scopically for the presence of erythrocytes, leukocytes, and
E. histolytica trophozoites. The DNA was extracted using
a slightly modified QIAamp DNA Stool Mini Kit protocol
(Qiagen Inc., Valencia, CA) as described previously for
specimens from ICDDR,B [54]. Stool samples are also
listed in Additional file 1: Table S4.
E. histolytica DNA derived from Amebic Liver Abscess
(ALA) aspirates
Aspirates from patients with amebic liver abscesses were
obtained only from adults because ALA is an extremely
rare complication in children [55]. A presumptive diag-
nosis of ALA was based on clinical picture, ultrasound
examination and positive serology using an E. histolytica
antigen based ELISA (TechLab E. histolytica II) [6]. Ab-
scess fluid was obtained under ultrasound guidance from
patients with ALA and was purified using the modified
QIAamp DNA Stool Mini Kit protocol described above
(samples are listed in Additional file 1: Table S4) [6].
Primer design
Primers for these experiments were designed using
the publically available Primer3 program and checked
for specificity using the NCBI Primer-BLAST tool
[56] (http://www.ncbi.nlm.nih.gov/tools/primer-blast/).
All primers used in this study are listed in either
Additional file 1: Table S2 or Table S4.
Whole genome sequencing of axenic cultured
E. histolytica strains
Whole genome sequencing of five of the E. histolytica
strains used in this study was carried out at the J. Craig
Venter Institute. These sequence traces are deposited
at http://www.ncbi.nlm.nih.gov/bioproject/9532 dbSNPs
Genbank (http://www.ncbi.nlm.nih.gov/projects/SNP/)
and AmoebaDB (http://amoebadb.org/amoeba/) [57,58].
This project is also fully described at the NCBI Bio Pro-
ject page (Accession: PRJNA9532). Whole genome re-
sequencing was performed at the Institute of Integrative
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Liverpool and results deposited at AmoebaDB [35,57].
For a complete list of E. histolytica genomes, sequen-
cing technology and Sequencing Center see Table 1 and
Additional file 1: Table S1.SNP detection and selection of candidate
informative SNPs
For genome-wide SNP detection at JCVI the se-
quenced strains were analyzed using the CLC Genom-
ics Workbench 4.0.2 SNP detection component as
described below (see SNP detection and validation of
amplicon sequences). In genomes sequenced at the
Centre for Genomic Research, SNPs were identified
according to the methods described Weedall et al. [35].
For a list of the SNP detection method used in each
genome see Additional file 1: Table S1. SNPs are listed
in Additional file 1: Table S5. The default in the table
was Reference and only high confidence SNPs (se-
quence coverage >8) were identified as Non-Reference.
At selected locations a visual inspection of available se-
quence traces was performed to identify lower confi-
dence SNPs (Additional file 1: Table S6). To identify
“ancestral” or genetically stable SNPs we selected SNPs
that were present in more than three strains. To pick
out SNPs linked to disease the SNPs were grouped
according whether the sequenced genome was first iso-
lated from patients with asymptomatic or symptomatic
disease. The list of weighted selection criteria included
whether the SNPs enriched asymptomatic or symptom-
atic isolates, if the SNP was present in repeat regions
or large E. histolytica protein families, whether it was
contained in genes with any potential role in virulence,
or if orthologous sequences were present in the non-
pathogenic but closely related species E. dispar [37].
The selected SNPs are shown in Additional file 1:
Table S6.Preliminary amplicon sequencing and validation
PCR amplifications were performed on a C1000 Thermal
Cycler (Bio-Rad) using the High Fidelity Phusion DNA
polymerase Master Mix (Finnzymes). Sample DNA
(0.5 μl) was added to a 25 μl reaction mix containing
125 pm of the designated primers (5 nM). After an ini-
tial denaturation step of 98°C, denaturation at 98°C for
10 sec, annealing of primers at 50°C for 30 sec and
elongation at 72°C for 30 sec was performed for 34
cycles. This was followed by a final extension at 72°C for
10 min. The amplified products were separated on a 2%
agarose gel and the DNA fragments of the correct size
were gel purified and sequenced by Sanger sequencing
(GENEWIZ, Inc).PCR amplification of SNP markers and preparation
ofmuliplexed sequencing libraries
For clinical samples and low copy number culture ma-
terial, amplicons were generated by nested PCR (see
Additional file 1: Table S2 and S3). PCR amplifications
were carried out using Phusion High Fidelity DNA poly-
merase Master Mix (Finnzymes). 1 μl of first round
amplified DNA was used as template for the second
round of amplification, using the same conditions as for
the first round PCR with the exception that the anneal-
ing temperature was increased to 60°C and the nested
PCR primers were used with tails that contained the
unique “barcode” sequences and adaptors necessary for
Illumina paired-end sequencing, as described by Meyer
and Kircher (Additional file 1: Table S4) [59]. DNA from
cultured parasites was used directly as template for the
second round PCR amplification only, as its more abun-
dant template made nested PCR unnecessary.
After this step, the different PCR products amplified
from original samples were pooled in groups of 5 or 6
and one μl was amplified using 200 nM of the IS4 pri-
mer and an indexing primer (Additional file 1: Tables S2
and S4) for an initial denaturation step of 98°C, denatur-
ation at 98°C for 10 sec, annealing of primers at 60°C for
20 sec and elongation at 72°C for 20 sec was performed
for 34 cycles. This was followed by a final extension at
72°C for 10 min.
The final amplification product was pooled and puri-
fied using the Qiagen MinElute 96 UF PCR purification
kit according to manufacturer’s directions, and an ali-
quot of the amplified library and the accompanying
negative controls were run on a 2% agarose gel for qual-
ity control. The final library was pooled and DNA con-
centration determined using a Quant-iT Kit (Invitrogen).
Prior to submission for sequencing the size distribution
of the DNA in the pooled library sample was examined
for insert sizes and confirmed to be of the expected
range (200–300 bp) using an Agilent 2100 bioanalyzer.Illumina paired-end sequencing of amplicons containing
SNP markers
An aliquot of the multiplexed libraries (5 pmol) was
denatured and then processed with the Illumina Cluster
Generation Station at the J. Craig Venter Institute, Rock-
ville, MD (JCVI, MD, USA), following the manufacturers
protocol. Libraries were sequenced on an Illumina GAII,
run for 100 cycles to produce reads of 100 bp. Images
were collected over 120 tiles (one lane) which contained
715,000 ±60 clusters per tile.Data filtering and analysis pipeline
After the run image analysis, base calling and error esti-
mation were performed using Illumina/Solexa Pipeline
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sequences according to indexes CASAVA 1.6 (Illumina).
Alignment of sequence reads and SNP typing
Amplicon sequence analysis was performed using the
high-throughput sequencing module of CLC Genomics
Workbench 4.0.2. Raw read output for each indexed
amplicon set (derived from samples as indicated in
Additional file 1: Table S4) was cleaned by trimming of
adaptor sequences, ambiguous nucleotides and low
quality sequences with average quality scores less than
20. The remaining reads were used for reference as-
sembly. To assess the level of redundancy and non-
specific alignment in each individual dataset, an initial
reference-based assembly was executed using the whole
E. histolytica HM-1:IMSS reference genome (Genbank
accession AAFB00000000). As some level of non-
specific alignment occurred, the alignment conditions
utilized for the final mapping of Illumina reads to the
reference assembly were adjusted to require a global
alignment of 80% identity over at least 80% of the spe-
cific concatenated reference assembly of the target se-
quences (see Additional file 1: Table S3). Default local
alignment settings with mismatch cost of 2, deletion
cost of 3 and insertion cost of 3 were used. Reads that
were not assembled into contigs in the reference as-
sembly were not analyzed. Consensus sequences de-
rived from the reference assemblies for each amplicon
set were utilized for SNP scoring and further phylogen-
etic analysis.
SNP detection in the amplified DNA was performed
using CLC Genomics Workbench 4.0.2 SNP detection
component, which is based on the Neighborhood Qual-
ity Standard (NQS) algorithm [60]. To identify quality
SNPs, putative SNPs were screened following specific
criteria based on the read depth, minor allele frequency
(10%), the quality of flanking regions and absence of
other SNPs within 15-bp flanking regions. SNPs located
in repetitive regions were also not considered. The cen-
tral base quality score of ≥30 and average surrounding
base quality score of ≥20 were set to assess the quality of
reads at positions for SNP detection. A minimum cover-
age of 10 and a minimum variant frequency of two was
required, and the variations compared against the refer-
ence sequence were counted as SNPs. The NQS algo-
rithm looked at each position in the genome alignment
to determine if there was a SNP at that position.
Statistical analysis
The sequences spanning the SNPs were extracted and the
IUB base code guide used to describe heterologous bases
(see Additional file 1: Table S8). At each locus the sum of
the squared allele frequencies was subtracted from 1 to
gauge the diversity (heterozygosity) in both the originalsequenced genomes and the new MLST data (Figure 2).
The E. dispar Mercator whole genome alignment depos-
ited in AmoebaDB was used to obtain the equivalent
sequences where they existed in this related species (Add-
itional file 1: Table S8) [57,61]. The statistical significance
of SNP distribution or genotype group versus the pheno-
typic manifestation of disease (asymptomatic/diarrhea or
dysentery/amebic liver abscess) was determined by use of
a Chi-squared contingency test or Fisher’s Exact test using
the Prism 5 program (GraphPad Software) and the result-
ing p values were corrected for multiple comparisons by
use of the false discovery rate formula of Benjamini and
Hochberg in the R program FDR online calculator made
freely available by the SDM project [62,63]. To obtain the
correction for multiple comparisons in the pairwise com-
parison the p-values of all possible combinations (i.e.
asymptomatic vrs dysentery; asymptomatic vrs amebic
liver abscess; dysentery vrs amebic liver abscess) for a
given data set were combined prior to correction. A FDR
of 10% was considered significant (http://sdmproject.com/
utilities/?show=FDR_).Additional files
Additional file 1: Supplemental Tables. This file includes all
supplemental tables mentioned in the text in an excel spreadsheet.
Additional file 2: Figure S1. This word document file (.dox) includes
Additional file 2: Figure S1 describing the LCAT superfamily.Competing interests
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